 <p><strong>Improving Patient Access to Care and Treatment Act</strong></p> <p>This bill increases the number of days&#8212;from 14 to 60&#8212;within which a practitioner must administer certain narcotic drugs (e.g., buprenorphine) to a patient for maintenance or detoxification treatment (i.e., substance use disorder treatment) after receiving the drugs from a pharmacy.</p>